Q32 Bio Inc.

Ownership Transactions Reported by 28 Insiders

Symbol
QTTB on Nasdaq
Industry
Pharmaceutical Preparations
Location
830 Winter Street, Waltham, MA

There are no Buy or Sell transactions made by insiders since 4/22/2024

Q32 Bio Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Albert Seymour President and Chief Executive Officer, Director $8.58M Sep 6, 2023
Jodie Pope Morrison CEO, Director $6.26M Feb 24, 2025
W. Bradford Smith Chief Financial and Business Officer and Treasurer $2.91M Feb 23, 2023
Lee Kalowski CFO and President $2.55M Feb 24, 2025
Diyong Xu Director $1.46M Feb 24, 2025
Michael L. Blum Chief Commercial Officer $1.42M Feb 23, 2023
Orbimed Advisors Llc Director, 10%+ Owner $1.29M Mar 25, 2024
David S. Grayzel Director $1.23M Jan 15, 2025
Jason Campagna Chief Medical Officer $1.22M Feb 24, 2025
Atlas Venture Fund X, L.P. 10%+ Owner $1.19M Mar 25, 2024
Shelia M. Violette Chief Scientific Officer $1.15M Feb 24, 2025
Timothy P. Kelly Chief Operating Officer $385K Feb 24, 2022
Arthur Tzianabos Director $365K Feb 24, 2025
Mark T. Iwicki Director $343K Feb 24, 2025
Jeffrey V. Poulton Director $309K Jun 14, 2023
Steven Gillis Director $309K Jun 14, 2023
Matthew R. Patterson Director $309K Jun 14, 2023
Alise Reicin Director $309K Jun 14, 2023
Richard J. Gregory Director $242K Jun 15, 2022
Kush Parmar Director $242K Jun 15, 2022
Kathleen Laporte Director $174K Feb 24, 2025
Mary Thistle Director $171K Feb 24, 2025
Isaac Manke Director $35.3K Jan 15, 2025
Sven Ante Lundberg Director $18.3K Jan 15, 2025
Gabriel Cohn Chief Medical Officer $11.5K Jan 1, 2022
Julie Jordan Chief Medical Officer $4.24K Aug 3, 2023
Paul Alloway Former President and Chief Operating Officer of Homology Medicines, Inc. $1.48K Mar 25, 2024
Charles Michaud Jr Former Vice President, Corporate Controller and Treasurer of Homology Medicines, Inc. $529 Mar 25, 2024

Recent Insider Transactions by Companies or Individuals for Q32 Bio Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.